Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.Trump: The Middle East issue is easier to solve than the Russian-Ukrainian issue. Trump was interviewed by Time magazine in the United States. One of the questions was: "It is reported that you told Israeli Prime Minister Benjamin Netanyahu that you wanted him to end the Gaza war before you took office. What did he say about it? " Trump replied: "Before I talk about this issue, I think the Middle East issue is easier to deal with than the situation in Russia and Ukraine ... As we talk, things in the Middle East are going on very productively." However, Trump refused to disclose what exactly "something productive is happening" means. Asked whether he supports the "two-state solution" to the Palestinian-Israeli issue, Trump said: "I support the peace plan, which can take different forms. When I wrote the Abraham Agreement, it should have covered many people. "China Seismological Network officially measured that a magnitude 3.1 earthquake occurred at 17: 09 on December 13th in Kuqa City, Aksu Prefecture, Xinjiang (41.23 degrees north latitude and 83.31 degrees east longitude) with a focal depth of 21 kilometers.
HKEx: HSBC repurchased 527,200 shares for HK$ 39.4 million on December 12.The Kuala Lumpur Composite Index of Malaysia closed up 0.4% at 1,608.75.Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.
Spring Airlines: In November, the company's passenger transport capacity investment (in terms of available seat kilometers) increased by 10.36% year-on-year and decreased by 9.93% quarter-on-quarter; Passenger turnover (in terms of revenue passenger kilometers) increased by 12.73% year-on-year and decreased by 9.92% quarter-on-quarter; The load factor increased by 1.90% year-on-year and 0.02% quarter-on-quarter.Huang Hongfei, former CFO of McDonald's China, joined the company? Bawang Chaji: No response. Recently, it was reported in the market that Huang Hongfei, the former CFO of McDonald's China, recently left his post and joined Bawang Chaji after a short break. In response to this news, Bawang Chaji said that he would not respond. According to public information, Huang Hongfei joined McDonald's around 1995 and played an important role in the financial and strategic planning of McDonald's China. He was one of the key figures who witnessed the development of McDonald's China. (SSE)Hong Kong media revealed that French President Macron plans to visit China in the new year. On the 13th, Hong Kong's South China Morning Post quoted several people familiar with the matter as saying that French President Macron plans to visit China in the new year. The report mentioned that Bona, foreign affairs adviser to the French President, took a team of assistants to China this week to "act as an advance stop" for Macron's visit to China in 2025. (World Wide Web)
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide